Abstract

Reimbursement of medical devices based on Heath Technology Assessment (HTA) has become increasingly important. In Canada, decision-making is highly decentralized, and evaluations of devices are not mandatory on a national level; local level stakeholders are the final decision-makers for reimbursement based on allocated budgets, clinical need, and healthcare objectives. This research aims to explore the current HTA landscape of medical devices in Canada.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call